Diabetes Care (2010) 33:11735
People with diabetes who are also taking insulin or sulfonylureas would face an additional risk of hypoglycaemia, and such combinations should only ever be considered within a closely supervised clinical trial setting
2019;2019:3150145 Lo M, Ling V, Wang YZ, Gout PW
doi:10.3390/v15061314 Wojciech K, Bankova V, Sforcin JM, Szliszka E, Czuba Z, Kuropatnicki A
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
Impact of dietary Spirulina on performance, antioxidant status, carcass traits and pathological alteration in broilers exposed to ochratoxin A stress